Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: Retrospective analysis of a single institution experience

Author：          

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.1, 2014-01, pp. : 428-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The role of enzalutamide in the treatment of castration-resistant prostate cancer

By Rawlinson Alex   Mohammed Aza   Miller Marek   Kunkler Roger  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1073-1081

Future Medicine

Access to resources Recommend Favorite

Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1040-1045

Bentham Science Publishers

Access to resources Recommend Favorite

Single Agent Vinflunine in the Salvage Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Trial of the Sarah Cannon Research Consortium

By Hainsworth John D.   Meluch Anthony A.   Lane Cassie M.   Spigel David R.   Burris Howard A.   Gandhi Jitendra G.   Crane Edward J.   Stipanov Michael A.   Greco F. Anthony  

Cancer Investigation, Vol. 28, Iss. 3, 2010-03 ,pp. : 275-279

Informa Healthcare

Access to resources Recommend Favorite

Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre

By  

Case Reports in Oncology, Vol. 9, Iss. 2, 2016-08 ,pp. : 506-515

Karger

Access to resources Recommend Favorite

Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study

By  

Oncology, Vol. 92, Iss. 2, 2016-12 ,pp. : 94-100

Karger

Access to resources Recommend Favorite